AKRO
Price
$47.47
Change
-$0.37 (-0.77%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
3.83B
49 days until earnings call
ETNB
Price
$14.71
Change
-$0.03 (-0.20%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
2.19B
43 days until earnings call
Interact to see
Advertisement

AKRO vs ETNB

Header iconAKRO vs ETNB Comparison
Open Charts AKRO vs ETNBBanner chart's image
Akero Therapeutics
Price$47.47
Change-$0.37 (-0.77%)
Volume$24.26K
Capitalization3.83B
89bio
Price$14.71
Change-$0.03 (-0.20%)
Volume$37.94K
Capitalization2.19B
AKRO vs ETNB Comparison Chart in %
Loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKRO vs. ETNB commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKRO is a Hold and ETNB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (AKRO: $47.84 vs. ETNB: $14.74)
Brand notoriety: AKRO and ETNB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKRO: 85% vs. ETNB: 300%
Market capitalization -- AKRO: $3.83B vs. ETNB: $2.19B
AKRO [@Biotechnology] is valued at $3.83B. ETNB’s [@Biotechnology] market capitalization is $2.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKRO’s FA Score shows that 0 FA rating(s) are green whileETNB’s FA Score has 0 green FA rating(s).

  • AKRO’s FA Score: 0 green, 5 red.
  • ETNB’s FA Score: 0 green, 5 red.
According to our system of comparison, ETNB is a better buy in the long-term than AKRO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKRO’s TA Score shows that 4 TA indicator(s) are bullish while ETNB’s TA Score has 5 bullish TA indicator(s).

  • AKRO’s TA Score: 4 bullish, 4 bearish.
  • ETNB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both AKRO and ETNB are a good buy in the short-term.

Price Growth

AKRO (@Biotechnology) experienced а +12.30% price change this week, while ETNB (@Biotechnology) price change was +84.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was +10.70%, and the average quarterly price growth was +54.52%.

Reported Earning Dates

AKRO is expected to report earnings on Nov 12, 2025.

ETNB is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKRO($3.83B) has a higher market cap than ETNB($2.19B). ETNB YTD gains are higher at: 88.491 vs. AKRO (71.963). AKRO has higher annual earnings (EBITDA): -279.17M vs. ETNB (-442.86M). AKRO has more cash in the bank: 742M vs. ETNB (561M). AKRO (37.2M) and ETNB (37.6M) have identical debt. AKRO (0) and ETNB (0) have equivalent revenues.
AKROETNBAKRO / ETNB
Capitalization3.83B2.19B175%
EBITDA-279.17M-442.86M63%
Gain YTD71.96388.49181%
P/E RatioN/AN/A-
Revenue00-
Total Cash742M561M132%
Total Debt37.2M37.6M99%
FUNDAMENTALS RATINGS
AKRO vs ETNB: Fundamental Ratings
AKRO
ETNB
OUTLOOK RATING
1..100
6684
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
39
Fair valued
PROFIT vs RISK RATING
1..100
77100
SMR RATING
1..100
9799
PRICE GROWTH RATING
1..100
5436
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AKRO's Valuation (35) in the null industry is in the same range as ETNB (39). This means that AKRO’s stock grew similarly to ETNB’s over the last 12 months.

AKRO's Profit vs Risk Rating (77) in the null industry is in the same range as ETNB (100). This means that AKRO’s stock grew similarly to ETNB’s over the last 12 months.

AKRO's SMR Rating (97) in the null industry is in the same range as ETNB (99). This means that AKRO’s stock grew similarly to ETNB’s over the last 12 months.

ETNB's Price Growth Rating (36) in the null industry is in the same range as AKRO (54). This means that ETNB’s stock grew similarly to AKRO’s over the last 12 months.

ETNB's P/E Growth Rating (100) in the null industry is in the same range as AKRO (100). This means that ETNB’s stock grew similarly to AKRO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AKROETNB
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 6 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RGNCX38.330.43
+1.13%
Victory Global Energy Transition C
SPSDX19.570.03
+0.15%
Sterling Capital Behav Sm Cp Val Eq C
TRAIX38.21-0.08
-0.21%
T. Rowe Price Capital Appreciation I
LYRBX29.79-0.13
-0.43%
Lyrical US Value Equity Investor
ARTMX39.06-0.44
-1.11%
Artisan Mid Cap Investor

AKRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKRO has been loosely correlated with ETNB. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if AKRO jumps, then ETNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKRO
1D Price
Change %
AKRO100%
+3.08%
ETNB - AKRO
53%
Loosely correlated
-0.87%
SLS - AKRO
42%
Loosely correlated
-1.16%
VTYX - AKRO
38%
Loosely correlated
-1.06%
MDGL - AKRO
37%
Loosely correlated
+0.74%
NAUT - AKRO
35%
Loosely correlated
+2.11%
More

ETNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETNB has been loosely correlated with AKRO. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ETNB jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETNB
1D Price
Change %
ETNB100%
-0.87%
AKRO - ETNB
53%
Loosely correlated
+3.08%
IDYA - ETNB
49%
Loosely correlated
+0.04%
NTLA - ETNB
47%
Loosely correlated
-1.04%
BEAM - ETNB
47%
Loosely correlated
-2.79%
ORIC - ETNB
45%
Loosely correlated
-3.14%
More